Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 43 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014" provides data on the Ampio Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Ampio Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Ampio Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Ampio Pharmaceuticals, Inc. - Brief Ampio Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ampio Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ampio Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ampio Pharmaceuticals, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Ampio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ampio Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ampio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ampio Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ampio Pharmaceuticals, Inc. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ampio Pharmaceuticals, Inc. Snapshot 5
Ampio Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Ampio Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Ampio Pharmaceuticals, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Ampio Pharmaceuticals, Inc. - Pipeline Products Glance 11
Ampio Pharmaceuticals, Inc. - Late Stage Pipeline Products 11
Pre-Registration Products/Combination Treatment Modalities 11
Phase III Products/Combination Treatment Modalities 12
Ampio Pharmaceuticals, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Ampio Pharmaceuticals, Inc. - Drug Profiles 14
tramadol hydrochloride 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Ampion 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
DMI-5207 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
DMI-4983 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
DMI-9523 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NCE-001 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Ampio Pharmaceuticals, Inc. - Pipeline Analysis 23
Ampio Pharmaceuticals, Inc. - Pipeline Products by Therapeutic Class 23
Ampio Pharmaceuticals, Inc. - Pipeline Products by Target 25
Ampio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 26
Ampio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 27
Ampio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 28
Ampio Pharmaceuticals, Inc. - Recent Pipeline Updates 29
Ampio Pharmaceuticals, Inc. - Dormant Projects 36
Ampio Pharmaceuticals, Inc. - Discontinued Pipeline Products 37
Discontinued Pipeline Product Profiles 37
tramadol hydrochloride 37
Ampio Pharmaceuticals, Inc. - Company Statement 38
Ampio Pharmaceuticals, Inc. - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
Ampio Pharmaceuticals, Inc., Key Information 5
Ampio Pharmaceuticals, Inc., Key Facts 5
Ampio Pharmaceuticals, Inc. - Pipeline by Indication, 2014 8
Ampio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Ampio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Ampio Pharmaceuticals, Inc. - Pre-Registration, 2014 11
Ampio Pharmaceuticals, Inc. - Phase III, 2014 12
Ampio Pharmaceuticals, Inc. - Preclinical, 2014 13
Ampio Pharmaceuticals, Inc. - Pipeline by Therapeutic Class, 2014 24
Ampio Pharmaceuticals, Inc. - Pipeline by Target, 2014 25
Ampio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 26
Ampio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 27
Ampio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 28
Ampio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 29
Ampio Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 36
Ampio Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 37
Ampio Pharmaceuticals, Inc., Subsidiaries 41